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The hypothesis that children whose families suffer from autoim-
mune disease have increased risk of haematopoietic malignancies
was first raised in 1979 (Till et al, 1979). Since then, a few small
epidemiological studies have tested the hypothesis (Till et al,
1979; McKinney et al, 1987; Woods et al, 1987; Buckley et al,
1989, 1994; Wen et al, 1998), providing some support for the
association. Further support comes from evidence that inherited
susceptibility to Hodgkin’s disease, and possibly, also acute
lymphocytic lymphoma (ALL), is linked to HLA class II (Bodmer
et al, 1989; Tonks et al, 1992; Klitz et al, 1994; Taylor et al, 1995,
1996, 1998) as is the case for most autoimmune diseases
(Deodhar, 1992). Best available epidemiological evidence
suggests that childhood leukaemias and lymphomas arises as a
rare sequela of certain patterns of exposure to infection (Doll,
1999). For the dominant subtype of ALL, common ALL, it has
been proposed that leukaemia follows an overly florid immune
response (Greaves, 1997), as is believed to occur in autoimmune
disease.
In this nationwide study from Denmark, the incidences of
malignant lymphoma, leukaemia and other childhood cancers
were evaluated in a large cohort of offspring of patients with
autoimmune disease ascertained through a hospitalization register
and compared with that of the general childhood population.
MATERIALS AND METHODS
The study population comprised the children of 36 654 patients
born after 1 January 1930 and registered in the Danish National
Registry of Patients, primarily during 1977–1993 with one or more
of the autoimmune diseases shown in Table 1. The National
Registry of Patients contains information about more than 99% of
hospitalizations in non-psychiatric hospitals, with registration of
the personal identification number, dates of hospitalization and up
to 20 discharge diagnoses coded according to a Danish modified
version of ICD-8 (Danish National Board of Health, 1976). The
autoimmune diseases included cover a wide spectrum of diseases,
which may be divided into three main categories: systemic (28%
of patients), organ-specific (31%) and suspected autoimmune
diseases (42%) (Table 1).
The Danish Central Population Register (CPR) was established
on 1 April 1968, when all residents of Denmark were assigned a
unique personal identification number which includes the sex and
date of birth of the individual. Since that date, the identification
number has been given to all children at birth. The Register keeps
track of all persons ever assigned an identification number in respect
of vital status and addresses; in addition, the Register includes a
cross-reference between children and parents alive on 1 April 1968
who were registered at the same address. Because of the latter
condition, we chose to restrict the study population to children
of parents born after 1930. We were thus able to trace
56 052 children in the CPR, corresponding to 1.5 children per
parent. Of these, we excluded 197 children from Greenland, 2043
children who were born after 1993 and one child whose ‘parent’ was
only 10 years old at the time of the child’s birth, thus leaving 53 811
children for follow-up for cancer. For these children, the fathers with
autoimmune disease were on average 28.4 years old when the child
was born, while the mothers with autoimmune disease were on
average 25.7 years old at the time of the birth of the child.
The offspring were followed for childhood cancer from their
date of birth or the date for establishment of the CPR (1 April
1968), whichever occurred latest, until the date of cancer diag-
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December 1993. Cases of cancer occurring during the follow-up
were ascertained by linkage to the Danish Cancer Registry, which
receives notifications from clinicians whenever a malignant
neoplasm, a benign tumour in the nervous system or a papilloma
of the urinary tract is diagnosed or when changes in the initial
diagnosis occur. All tumours are coded according to a revised
version of ICD-7 (Danish National Board of Health, 1998), and
since 1978 also according to ICD-O (World Health Organization,
1976). We grouped tumours diagnosed during childhood by a
classification scheme for childhood cancers prepared by the
International Agency for Research on Cancer (Birch and Marsden,
1987), which is based on ICD-O. For childhood cancers registered
before 1978, the original diagnosis given on the notification forms
has been reviewed and an ICD-O code assigned to each tumour, as
described previously (Brown et al, 1989), so that the childhood
cancer classification scheme could be used throughout the study
period, 1968–1993.
The expected numbers of tumours were calculated from accu-
mulated person-years and national childhood cancer incidence
rates for each sex and for specific age groups (< 1, 1–4, 5–9, 10–14
and 15–19 years) and 5-year calendar periods. As a measure of the
relative risk, standardized incidence ratios (SIR) were computed
by dividing the expected number into the observed number; 95%
confidence intervals (CI) were calculated assuming a Poisson
distribution of the observed numbers by Byar’s approximation
(Rothman and Boice, 1979).
RESULTS
The offspring cohort consisted of 28 148 (52%) males and 25 663
(48%) females. The date of entry was equal to the date of birth for
61% of the children, while 32% entered the cohort at the ages of
1–10 years. Of the offspring, 188 were themselves reported to
have an autoimmune disease in the files of the National Registry
of Patients; none of these had a diagnosis of cancer during child-
hood.
During the childhood follow-up period that continued until the
age of 20, 750 581 person-years were accrued, with an average
follow-up of 13.9 years. A total of 115 cancers were observed,
which resulted in a SIR of 1.07 (95% CI 0.89–1.29) (Table 2). The
risk for lymphomas was increased by 1.6-fold on the basis of 21
observed cases (95% CI 1.0–2.4); these included four cases of
Burkitt’s lymphoma (SIR 3.1; 95% CI 0.8–7.9). There were 37
cases of leukaemia, whereas 28.2 were expected, to yield a SIR of
1.3 (95% CI 0.9–1.8). Among the specific types of leukaemia, 
the largest increase in risk was seen for acute non-lymphocytic
leukaemia (ANLL: SIR 1.9; 95% CI 0.9–3.7), whereas no excess
risk was observed for ALL (SIR 1.1; 95% CI 0.7–1.7). There was
no excess risk for any other type of childhood cancer.
There was no apparent difference between boys and girls in the
risk for either lymphoma or leukaemia (Table 3). When age at
cancer diagnosis was considered, the excess of lymphomas was
most pronounced in children aged 1–14 years, while for
leukaemias there was an excess of infant leukaemia (< 1 year) and
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Table 1 Numbers of patients with systemic, organ-specific and suspected autoimmune disease and the number of offspring
Autoimmune diseasea ICD-8 Period in the NRP No. of patients No. of offspring
All 36 654 53 811
Systemic autoimmune diseasesb 10 159 15 487
Systemic scleroderma 734.0 1977–1993 376 573
Rheumatoid arthritis 712.0–712.3, 712.5 1977–1993 8 012 12 294
Polymyositis/dermatomyositis 716.0–716.1 1977–1993 348 511
Systemic lupus erythematosus 734.1 1977–1993 1 163 1 588
Sjögren’s syndrome 734.90c 1977–1993 260 521
Organ-specific autoimmune diseasesb 11 225 14 396
Grave’s disease 242.00c 1977–1993 319 602
Hashimoto’s thyroiditis 245.03c 1977–1993 326 631
Juvenile diabetes mellitus 249.0 1987–1989 8 652 10 416
Pernicious anaemia 281.0 1977–1989 427 680
Autoimmune haemolytic anaemia 283.90c 1977–1993 103 99
Idiopathic thrombocytopenic purpura 287.10c 1977–1989 452 487
Primary biliary cirrhosis 571.90c 1977–1989 161 254
Localized scleroderma 701.0 1977–1993 365 600
Myasthenia gravis 733.0 1977–1993 420 627
Suspected autoimmune diseasesd 15 270 23 928
Sarcoidosis 135.9 1977–1993 3 412 5 802
Multiple sclerosis 340.0 1977–1993 4 809 7 457
Amyotrophic lateral sclerosis 348.0 1977–1993 280 506
Periarteritis nodosa 446.0 1977–1993 237 365
Wegener’s granulomatosis 446.2 1977–1993 152 206
Temporal arteritis and polymyalgia arterica 446.3 1977–1993 568 1 079
Ulcerative colitis 563.1 1977–1989 4 549 6 545
Ankylosing spondylitis 712.4 1977–1993 1 263 1 968
NRP, National Registry of Patients. aIn case of overlap between the main groups, the patient was counted in the group of highest priority (1, systemic; 2, 
organ-specific; 3, suspected). In case of overlap within a main group, the disease with the earliest date of hospitalization was counted. bThe classification of
diseases into systemic and organ-specific autoimmune diseases is slightly modified after Theofilopoulos (1993). cSpecific for the Danish modified version of
ICD-8. dTermed suspected autoimmune diseases according to Cid et al, 1989; Savage and Lockwood, 1990; Lakomek et al, 1991; Forgacs, 1993; Lucchinetti
and Rodriguez, 1997; Moller, 1997; Jackson and Bryan, 1998.of acute myelocytic and other leukaemia at the ages 1–19 years.
Excess risks were seen for both lymphoma and leukaemia among
children of fathers and of mothers with autoimmune diseases,
while no cases were observed among the 345 children who had
both a father and a mother with a relevant disease. The fathers
were on average 30.0 years of age and mothers 27.0 years when
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Table 2 Standardized incidence ratios (SIR) of childhood cancers among offspring of patients with autoimmune diseases followed up to their 20th birthday
Cancer site Obs Exp SIR 95% CI
All malignant neoplasms 115 107.1 1.07 0.89–1.29
Lymphomas and other reticuloendothelial neoplasms 21 13.6 1.6 1.0–2.4
Hodgkin’s disease 8 6.2 1.3 0.6–2.5
Non-Hodgkin’s lymphomas 7 4.5 1.5 0.6–3.2
Burkitt’s lymphoma 4 1.3 3.1 0.8–7.9
Unspecified lymphoma 2 1.2 1.6 0.2–5.8
Leukaemias 37 28.2 1.3 0.9–1.8
Acute lymphocytic 22 19.8 1.1 0.7–1.7
Acute non-lymphocytic 9 4.6 1.9 0.9–3.7
Chronic myelocytic 1 0.8 1.3 0.0–7.2
Other and unspecified 5 3.0 1.7 0.5–3.9
Other types of neoplasms 57 65.3 0.9 0.7–1.1
Central nervous system 22 25.6 0.9 0.5–1.3
Sympathetic nervous system 5 5.3 0.9 0.3–2.2
Retinoblastomas 1 2.0 0.5 0.0–2.7
Renal tumours 1 4.9 0.2 0.0–1.1
Hepatic tumours 1 0.8 1.2 0.0–6.6
Malignant bone tumours 2 5.4 0.4 0.0–1.3
Soft-tissue sarcomas 8 5.9 1.4 0.6–2.7
Germ-cell, trophoblastic and other gonadal 8 7.1 1.1 0.5–2.2
Carcinomas, other and unspecified malignant 9 9.7 0.9 0.4–1.8
CI, confidence interval.
Table 3 Risks for leukaemia and lymphoma in childhood among offspring of patients with autoimmune diseases according to sex, age at time of diagnosis of
cancer, sex of the parent and type of autoimmune disease
No. of Lymphomas Leukaemias Combined
offspring
Variable Obs Exp SIR 95% CI Obs Exp SIR 95% CI SIR 95% CI
Sex
Male 28 148 13 9.2 1.4 0.8–2.4 20 16.3 1.2 0.8–1.9 1.3 0.9–1.8
Female 25 663 8 4.4 1.8 0.8–3.6 17 11.9 1.4 0.8–2.3 1.5 1.0–2.3
Age at diagnosis of cancer
Infant lymphoma/leukaemia (< 1 year) 0 0.2 – – 4 1.5 2.8 0.7–7.0 – –
Childhood lymphoma (1–14 years) 13 7.0 1.9 1.0–3.2 – – – – – –
Adolescent lymphoma (15–19 years) 8 6.4 1.3 0.5–2.5 – – – – – –
Peak ALL (1–4 years) – – – – 9 8.7 1.0 0.5–2.0 – –
Older ALL (5–19 years) – – – – 12 10.6 1.1 0.6–2.0 – –
Older AML and other (1–19 years) – – – – 12 7.6 1.6 0.8–2.8 – –
Parent with autoimmune disease
Father 22 218 10 5.6 1.8 0.9–3.3 18 12.1 1.5 0.9–2.4 1.6 1.1–2.3
Mother 31 248 11 7.9 1.4 0.7–2.5 19 16.0 1.2 0.7–1.9 1.3 0.9–1.8
Both 345 0 0.1 – – 0 0.2 – – –
Type of autoimmune disease
Systemic 15 487 6a 4.2 1.4 0.5–3.1 12a 7.9 1.5 0.8–2.6 1.5 0.9–2.3
Father 4 340b 1 1.2 0.8 0.0–4.7 3 2.3 1.3 0.3–3.8 1.1 0.3–2.9
Mother 10 989b 5 3.0 1.7 0.5–3.9 9 5.5 1.6 0.7–3.1 1.7 0.9–2.8
Organ-specific 14 396 4c 3.4 1.2 0.3–3.0 9c 7.4 1.2 0.6–2.3 1.2 0.6–2.1
Father 6 765b 3 1.7 1.8 0.4–5.3 8 3.6 2.2 1.0–4.3 2.1 1.0–3.7
Mother 7 518b 1 1.7 0.6 0.0–3.2 1 3.7 0.3 0.0–1.5 0.4 0.0–1.3
Suspected 23 928 11d 6.0 1.9 0.9–3.3 16e 12.9 1.2 0.7–2.0 1.4 0.9–2.1
Father 11 113b 6 2.7 2.2 0.8–4.8 7 6.1 1.2 0.5–2.4 1.5 0.8–2.5
Mother 12 741b 5 3.2 1.6 0.5–3.6 9 6.8 1.3 0.6–2.5 1.4 0.8–2.4
ALL, acute lymphocytic leukaemia; AML, acute myelocytic leukaemia. aAll parents had rheumatoid arthritis. bChildren whose parents both had an autoimmune
disease are not included. cAll parents had diabetes mellitus. dParents had sarcoidosis (n = 3), multiple sclerosis (n = 4), ulcerative colitis (n = 1) and ankylosing
spondylitis (n = 3). eParents had sarcoidosis (n = 3), multiple sclerosis (n = 5), amyothrophic lateral sclerosis (n = 2), polymyalgia arterica (n = 1), ulcerative
colitis (n = 4) and ankylosing spondylitis (n = 1).the child with leukaemia or lymphoma was born. For all 58 cases
of leukaemia and lymphoma, the parents were hospitalized for the
autoimmune disease subsequent to the birth of the child, but we do
not have a date of diagnosis of the autoimmune disease.
When considering the main type of autoimmune disease in the
parent, there was no statistical significant difference in risk for
either lymphoma or leukaemia, although the risk for lymphomas
tended to be higher among children of parents with suspected
autoimmune disease than among those of parents with systemic or
organ-specific disease (Table 3). The analysis of type of auto-
immune disease was further stratified according to whether the
mother or father had the disease in question. This analysis showed
that the increased risk for lymphoma and leukaemia was associ-
ated with maternal systemic disease and paternal organ-specific
disease and maternal or paternal suspected disease. The parental
systemic disease was rheumatoid arthritis for all 18 children with
lymphoma or leukaemia, the parental organ-specific disease was
diabetes mellitus for all 13 case children, while several different
suspected diseases were diagnosed in parents of the remaining 27
case children (multiple sclerosis n = 9, sarcoidosis n = 6, ulcerative
colitis n = 5, ankylosing spondylitis n = 4, amyotrophic lateral
sclerosis n = 2, polymyalgia arterica n = 1).
DISCUSSION
In this large cohort of children of parents with autoimmune
disease, we found a moderately increased risk for childhood
lymphomas and leukaemia of borderline statistical significance; it
accords, however, with the a priori hypothesis of an association
between autoimmune disease and childhood lymphoma and
leukaemia in offspring; these haematopoietic cancers were the
only types of childhood cancer out of many considered for which
an association was seen.
The background for investigating an association between
parental autoimmune disease and childhood haematopoietic
cancer is the convergence of aetiological hypotheses for auto-
immune disease and childhood leukaemia or lymphoma. Both
disease entities may arise as a rare response to exposure to one or
more infectious agents (Deodhar, 1992; Fox et al, 1992; Doll,
1999), the probability of this response being influenced by host
factors which include age and inherited factors. As infectious aeti-
ology may also be relevant for adult non-Hodgkin’s lymphoma,
the hypothesis may also be relevant to certain autoimmune
diseases and non-Hodgkin’s lymphoma within the same individual
(Kassan et al, 1978; Gridley et al, 1993; Mellemkjær et al, 1997).
Previous studies of the hypothesis are case–control studies,
potentially subject to recall bias. They have reported associations
of ALL with familial autoimmune disease (Till et al, 1979),
maternal multiple sclerosis (Buckley et al, 1989) and familial
ulcerative colitis (Buckley et al, 1994). A further study showed an
association between ALL and maternal antinuclear antibodies,
though not overt autoimmune disease (Woods et al, 1987).
Absence of an association has been reported for acute myeloid
leukaemia with familial autoimmune disease (Till et al, 1979),
parental multiple sclerosis with acute non-lymphoblastic
leukaemia and lymphomas (Buckley et al, 1989), parental connec-
tive tissue diseases (of which some are autoimmune) with
leukaemia or non-Hodgkin’s lymphoma (McKinney et al, 1987),
and infant leukaemia (which has distinct cytogenic and presumed
aetiological characteristics (Greaves, 1997)) with parental auto-
immune disease (Wen et al, 1998). Overall, these studies are not
adequate for an evaluation, since most of them only included up to
a few hundred cases of leukaemia and lymphoma, and definitions
of autoimmune diseases among family members differed widely
as did case groups.
The present study is, we believe, the first to evaluate the hypoth-
esis in a follow-up design. The possibility of identifying index
persons and their offspring through computerized, nationwide
registers meant that an extraordinarily large study population of
offspring could be collected. Another advantage of registry data in
comparison with data used in previous case–control studies is that
the information on autoimmune disease in the parents was
recorded independently of whether they had a child with cancer or
not. We restricted the index population to those born after 1930, as
children had to be living at home on 1 April 1968, when the CPR
was established, in order to be traced. Still, some children may
have been missed, but we have no reason to believe that these have
different cancer risk than those included. Children who died before
1968 cannot be found in the CPR; for this reason the earliest start
of follow-up is 1 April 1968, even for children born before to
avoid selection bias.
The index parents in the present study had been hospitalized for
treatment or evaluation of autoimmune disease. Even though the
first hospitalization was recorded after birth for all the children
with lymphoma or leukaemia observed, the disease may have been
diagnosed in the parents years before birth of the child. Two points
are pertinent. First, hospitalized patients may differ from non-
hospitalized in various ways including the spectrum of disease and
its severity. Secondly, our results relate to parental susceptibility to
autoimmune disease rather than disease current at the time of
index conception or birth.
Follow-up for cancer of more than 53 000 children of parents
with autoimmune diseases indicates that such children are slightly
more susceptible to childhood lymphoma and leukaemia than chil-
dren in general. Further studies are required to confirm this associ-
ation and to determine whether it is specific to certain types of
autoimmune disease or to autoimmune disease present at time of
conception.
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